Integrating Pharmacogenetics In Clinical Care

NACompletedINTERVENTIONAL
Enrollment

408

Participants

Timeline

Start Date

August 1, 2016

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Cardiovascular Disease
Interventions
GENETIC

SLCO1B1 Genotype

Polymerase chain reaction (PCR) assay for SLCO1B1 rs4149056, with possible results T/T, T/C, or C/C.

Trial Locations (1)

02130

VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston

All Listed Sponsors
lead

VA Office of Research and Development

FED

NCT02871934 - Integrating Pharmacogenetics In Clinical Care | Biotech Hunter | Biotech Hunter